Latest from
Excelligent Dx

"Excelligent's Lesley Cheng presents at the Eagleworks Innovation Centre Launch"

Lesley Cheng, CEO and Co-Founder of Excelligent, spoke on the Female Founders Panel at the Eagleworks LIVE launch — a high-energy afternoon that brought together over 280 industry professionals, researchers, students, and entrepreneurs to explore the power of partnerships and innovation.

"Excelligent launches with $1M investment from the Eagle Fund"

Excelligent was announced as one of the first two recipients of financial support from the Eagle Fund — a $1 million grant made possible through the fund's partnership between La Trobe University and government agency Breakthrough Victoria. The investment will accelerate development of Excelligent's blood-based diagnostic platform for neurodegenerative diseases.

Cheng L, Hill AF, et al.

Therapeutically harnessing extracellular vesicles

The field of extracellular vesicle (EV) research has developed rapidly over the last decade from the study of fundamental biology to a subject of significant clinical relevance. The potential of harnessing EVs in the diagnosis and treatment of diseases — including cancer and neurological and cardiovascular disorders — is now being recognized. Accordingly, the applications of EVs as therapeutic targets, biomarkers, novel drug delivery agents and standalone therapeutics are being actively explored.